Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Seagen Inc.
Sotio Biotech Inc.
Mural Oncology, Inc
M.D. Anderson Cancer Center
Five Prime Therapeutics, Inc.
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
Ikena Oncology
Stingthera, Inc.
Atreca, Inc.
Fate Therapeutics
Hoosier Cancer Research Network
Incyte Corporation
KitovPharma
Daiichi Sankyo
Aduro Biotech, Inc.